Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018 (2018), Article ID 3523126, 10 pages
https://doi.org/10.1155/2018/3523126
Research Article

The Investigation of the Effect and Mechanism of Sophora moorcroftiana Alkaloids in Combination with Albendazole on Echinococcosis in an Experimental Rats Model

1Medical College of Qinghai University, Xining 810001, China
2Qinghai Institute for Endemic Disease Prevention and Control, Xining 811602, China
3Qinghai University Affiliated Hospital, Xining 810016, China

Correspondence should be addressed to Fabin Zhang; moc.361@bfzcmhq

Received 10 October 2017; Revised 24 January 2018; Accepted 14 February 2018; Published 28 March 2018

Academic Editor: Vincenzo De Feo

Copyright © 2018 Fabin Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Valour, S. Khenifer, N. Della-Schiava et al., “Unusual growth rate during cystic echinococcosis,” Parasitology International, vol. 63, no. 2, pp. 275–277, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Kern, “Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH),” Parasitology International, vol. 55, pp. S273–S282, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. Q. Yuan, B. Li, S. Jiang, Q. Zhao, J. Duo, and X. Huang, “Gamma-Ray Treatment of,” BioMed Research International, vol. 2016, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  4. F. Samuel, A. Degarege, and B. Erko, “Efficacy and side effects of albendazole currently in use against Ascaris, Trichuris and hookworm among school children in Wondo Genet, southern Ethiopia,” Parasitology International, vol. 63, no. 2, pp. 450–455, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Jamshidi, M. Mohraz, M. Zangeneh, and A. Jamshidi, “The effect of combination therapy with albendazole and praziquantel on hydatid cyst treatment,” Parasitology Research, vol. 103, no. 1, pp. 195–199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kaur, P. Singhi, S. Singhi, and N. Khandelwal, “Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: A randomized, placebo-controlled double blind trial,” The Pediatric Infectious Disease Journal, vol. 28, no. 5, pp. 403–406, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. G.-S. Bao, D.-Z. Shi, and X.-M. Ma, “Effect of alkaloids from Sophora moorcroftiana on Echinococcus granulosus in mice,” Chinese journal of parasitology & parasitic diseases, vol. 23, no. 6, pp. 471-472, 2005. View at Google Scholar · View at Scopus
  8. S.-Y. Wang, Z.-L. Sun, T. Liu, S. Gibbons, W.-J. Zhang, and M. Qing, “Flavonoids from Sophora moorcroftiana and their synergistic antibacterial effects on MRSA,” Phytotherapy Research, vol. 28, no. 7, pp. 1071–1076, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. X. M. Ma, G. S. Bao, J. M. Wan et al., “Therapeutic effects of Sophora moorcroftiana alkaloids in combination with albendazole in mice experimentally infected with protoscolices of Echinococcus granulosus,” Brazilian Journal of Medical and Biological Research, vol. 40, no. 10, pp. 1403–1408, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Su, W. Yang, W. Meng et al., “Anti-proliferation effects of ethanolic extracts from Sophora moorcroftiana seeds on human hepatocarcinoma HepG2 cell line,” Natural Product Research (Formerly Natural Product Letters), pp. 1–4, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. A. A. A. El-Aal, N. S. M. El-Gebaly, A. S. Al-Antably, M. A. Hassan, and M. A. El-Dardiry, “Post-immunization immunohistochemical expression of caspase 3 and p53 apoptotic markers in experimental hydatidosis,” Revista Brasileira de Parasitologia Veterinária, vol. 25, no. 3, pp. 333–340, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. L. A. Lieberman and G. C. Tsokos, “The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 740619, 6 pages, 2010. View at Publisher · View at Google Scholar
  14. G.-H. Jin, T. Hirano, and M. Murakami, “Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation,” International Immunology, vol. 20, no. 6, pp. 783–789, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Ishikawa, K. Tsuboi, S. Takano, E. Uchimura, T. Nose, and T. Ohno, “Intratumoral injection of IL-2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor model,” Cancer Science, vol. 95, no. 1, pp. 98–103, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Ghasemi, T. Ghazanfari, R. Yaraee, P. Owlia, Z. M. Hassan, and S. Faghihzadeh, “Roles of IL-10 in ocular inflammations: a review,” Ocular Immunology and Inflammation, vol. 20, no. 6, pp. 406–418, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Fukazawa, S. Nishida, and E. A. Pretto, “Peak Serum AST Is a Better Predictor of Acute Liver Graft Injury after Liver Transplantation When Adjusted for Donor/Recipient BSA Size Mismatch (ASTi),” Journal of Transplantation, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  18. A. R. Srivastava, S. Kumar, G. G. Agarwal, and P. Ranjan, “Blunt abdominal injury: Serum ALT-A marker of liver injury and a guide to assessment of its severity,” Injury, vol. 38, no. 9, pp. 1069–1074, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Mosca, M. C. S. De Menezes, P. C. L. Dionigi, R. Stirbulov, and W. C. N. Forte, “C3 and C4 complement system components as biomarkers in the intermittent atopic asthma diagnosis,” Jornal de Pediatria, vol. 87, no. 6, pp. 512–516, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Zhang, Y. Liu, Z. Wang et al., “A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level,” Molecular and Cellular Endocrinology, vol. 411, pp. 75–85, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Haase and G. Fitze, “HSP90AB1: Helping the good and the bad,” Gene, vol. 575, no. 2, pp. 171–186, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Pan, X. Zhang, and Y. Wang, “Targeting JNK by a new curcumin analog to inhibit NF-kB-mediated expression of cell adhesion molecules attenuates renal macrophage infiltration and injury in diabetic mice,” PLoS ONE, vol. 8, no. 11, Article ID e79084, 2013. View at Publisher · View at Google Scholar
  23. B. Stoevring, J. L. Frederiksen, and M. Christiansen, “CRYAB promoter polymorphisms: Influence on multiple sclerosis susceptibility and clinical presentation,” Clinica Chimica Acta, vol. 375, no. 1-2, pp. 57–62, 2007. View at Publisher · View at Google Scholar · View at Scopus